(Q34142019)

31 July 2017

1 reference

title

Prevention of cytomegalovirus disease in recipients of solid-organ transplants (English)

1 reference

31 July 2017

0 references

1 reference

Paya CV

1

1 reference

31 July 2017

language of work or name

English

0 references

publication date

6 February 2001

1 reference

Clinical Infectious Diseases

31 July 2017

published in

1 reference

31 July 2017

volume

32

1 reference

31 July 2017

issue

4

1 reference

31 July 2017

page(s)

596-603

1 reference

Occult herpes family viruses may increase mortality in critically ill surgical patients

31 July 2017

cites work

1 reference

Cytomegalovirus reactivation and tumour necrosis factor

21 January 2018

1 reference

Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study.

21 January 2018

1 reference

Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.

21 January 2018

1 reference

A Controlled Trial of Ganciclovir to Prevent Cytomegalovirus Disease after Heart Transplantation

21 January 2018

1 reference

Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group [corrected].

21 January 2018

1 reference

A comparison of ganciclovir and acyclovir to prevent cytomegalovirus after lung transplantation.

21 January 2018

1 reference

Randomised comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipients

21 January 2018

1 reference

Comparison of intravenous ganciclovir followed by oral acyclovir with intravenous ganciclovir alone for prevention of cytomegalovirus and Epstein-Barr virus disease after liver transplantation in children

21 January 2018

1 reference

A Randomized Prospective Trial of Acyclovir and Immune Globulin Prophylaxis in Liver Transplant Recipients Receiving OKT3 Therapy

21 January 2018

1 reference

Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants.

21 January 2018

1 reference

Prevention of recurrent cytomegalovirus disease in renal and liver transplant recipients: effect of oral ganciclovir

21 January 2018

1 reference

Two grams daily of oral acyclovir reduces the incidence of cytomegalovirus disease in CMV-seropositive liver transplant recipients

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/318724

1 reference

31 July 2017

1 reference